Literature DB >> 18398085

Expanding the treatment options for hepatocellular carcinoma: combining transarterial chemoembolization with radiofrequency ablation.

Andrew X Zhu, Ghassan K Abou-Alfa.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18398085     DOI： 10.1001/jama.299.14.1716

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study.

Authors:  Jeong Han Kim; Hyung Joon Yim; Kwang Gyun Lee; Seung Young Kim; Eun Suk Jung; Young Kul Jung; Ji Hoon Kim; Yeon Seok Seo; Jong Eun Yeon; Hong Sik Lee; Soon Ho Um; Kwan Soo Byun; Ho Sang Ryu
Journal:  Hepatol Int       Date:  2011-07-05       Impact factor: 6.047

2.  Embolization of liver tumors: Past, present and future.

Authors:  Ashwin Rammohan; Jeswanth Sathyanesan; Sukumar Ramaswami; Anand Lakshmanan; Perumal Senthil-Kumar; Ulagendra Perumal Srinivasan; Ravi Ramasamy; Palaniappan Ravichandran
Journal:  World J Radiol       Date:  2012-09-28

3.  Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future.

Authors:  Beat M Künzli; Paolo Abitabile; Christoph A Maurer
Journal:  World J Hepatol       Date:  2011-01-27

4.  Computed Tomography-Guided Radiofrequency Ablation Following Transcatheter Arterial Embolization in Treatment of Large Hepatic Hemangiomas.

Authors:  Jiansong Ji; Jun Gao; Lizhen Zhao; Jianfei Tu; Jingjing Song; Wenbing Sun
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Predicting the prognosis of hepatocellular carcinoma with the treatment of transcatheter arterial chemoembolization combined with microwave ablation using pretreatment MR imaging texture features.

Authors:  Jun Liu; Yigang Pei; Yu Zhang; Yifan Wu; Fuquan Liu; Shanzhi Gu
Journal:  Abdom Radiol (NY)       Date:  2021-01-01

6.  Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma.

Authors:  Xuhua Duan; Juanfang Liu; Xinwei Han; Jianzhuang Ren; Hao Li; Fengyao Li; Shuguang Ju
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.